These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2186351)

  • 1. Evaluation of aztreonam and ampicillin vs. amikacin and ampicillin for treatment of neonatal bacterial infections.
    Umaña MA; Odio CM; Castro E; Salas JL; McCracken GH
    Pediatr Infect Dis J; 1990 Mar; 9(3):175-80. PubMed ID: 2186351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
    Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S
    Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clindamycin plus amikacin versus clindamycin plus aztreonam in established intraabdominal infections.
    Barboza E; del Castillo M; Yi A; Gotuzzo E
    Surgery; 1994 Jul; 116(1):28-35. PubMed ID: 8023265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial using piperacillin versus ampicillin and amikacin for treatment of premature neonates with risk factors for sepsis.
    Hammerberg O; Kurnitzki C; Watts J; Rosenbloom D
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):241-4. PubMed ID: 2496993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with aztreonam for treatment of infections in children.
    Stutman HR
    Rev Infect Dis; 1991; 13 Suppl 7():S582-5. PubMed ID: 2068462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxalactam therapy for neonatal meningitis due to gram-negative enteric bacilli. A prospective controlled evaluation.
    McCracken GH; Threlkeld N; Mize S; Baker CJ; Kaplan SL; Faingezicht I; Feldman WE; Schaad U
    JAMA; 1984 Sep; 252(11):1427-32. PubMed ID: 6381775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of the combination of aztreonam with cefotaxime in the treatment of severe nosocomial pneumonia. Comparative study against amikacin combined with cefotaxime.
    Torres A; de Celis R; Rabinad E; Marco F; Almela M; Deulofeu R; Rodriguez-Roisin R; Agusti Vidal A
    Chemotherapy; 1989; 35 Suppl 1():15-24. PubMed ID: 2659289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aztreonam therapy in neutropenic patients with cancer.
    Jones PG; Rolston KV; Fainstein V; Elting L; Walters RS; Bodey GP
    Am J Med; 1986 Aug; 81(2):243-8. PubMed ID: 3526885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli.
    DeMaria A; Treadwell TL; Saunders CA; Porat R; McCabe WR
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1137-43. PubMed ID: 2679368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study on aztreonam, ceftazidime and amikacin in the treatment of complicated urinary tract infections.
    Melekos MD; Skoutelis A; Chryssanthopoulos C; Bassaris HP
    J Chemother; 1991 Dec; 3(6):376-82. PubMed ID: 1819621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
    Rabinad E; Bosch-Perez A
    Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of aztreonam in neonatal infections].
    Okura K; Matsuda T; Nigami H; Yamakawa M; Kuroki S; Haruta T; Kobayashi Y
    Jpn J Antibiot; 1990 Mar; 43(3):493-502. PubMed ID: 2374299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of ceftazidime vs. carbenicillin and amikacin for treatment of neonatal septicemia.
    Odio CM; Umana MA; Saenz A; Salas JL; McCracken GH
    Pediatr Infect Dis J; 1987 Apr; 6(4):371-7. PubMed ID: 3295738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia.
    Casali A; Ameglio F; Gionfra T; Tonachella R; Paoletti G; Gallo Curcio C
    Chemioterapia; 1987 Dec; 6(6):440-4. PubMed ID: 3325175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
    Clergeot A; Steru D; Rosset MA; Carbon C
    Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of amikacin and either ampicillin or cephalotin as initial treatment of febrile neutropenic patients.
    Palmblad J; Lönnqvist B
    Acta Med Scand; 1982; 212(6):379-84. PubMed ID: 6760676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
    Scully BE; Neu HC
    Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group.
    Marco V; Gobernado M; Santos M; Rabinad E
    Chemotherapy; 1989; 35 Suppl 1():81-8. PubMed ID: 2659295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.